DJS Antibodies

📍 Oxford, United Kingdom🗓 Founded 2014👥 18 employees💰 Last funded Nov 2021
Biotechnology Research🌐 djsantibodies.com
Website LinkedIn
At DJS we are developing novel therapeutics to treat chronic inflammatory diseases. We do this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. Our breakthrough technology enables us to produce first-in-class antibody therapeutics to previously intractable disease targets.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in DJS Antibodies?
DJS Antibodies has 1 investors on record on gritt.io and 1 late-stage investors.
When did DJS Antibodies last raise funding?
The most recent investment in DJS Antibodies recorded on gritt.io was in November 2021.
When was DJS Antibodies founded?
DJS Antibodies was founded in 2014.
What industry is DJS Antibodies in?
DJS Antibodies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is DJS Antibodies based?
DJS Antibodies is headquartered in Oxford, United Kingdom.